Crossmark

Mechanistic insights into nicardipine’s anti-colitic action: inhibition of pro-inflammatory cytokines, attenuation of oxidative stress, and protection of the mucosal barrier

Crossref DOI link: https://doi.org/10.1007/s11033-026-11697-y

Published Online: 2026-03-20

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Joda, Ali M.

Zalzala, Munaf H.
License Information

Text and Data Mining valid from 2026-03-20

Version of Record valid from 2026-03-20
More Information

Article History

Received: 12 November 2025

Accepted: 12 March 2026

First Online: 20 March 2026

Declarations

:

: The authors declare no competing interests.

: The Research Ethics Committee of the University of Baghdad’s College of Pharmacy officially authorized this study. All experimental procedures and tests were carried out in strict accordance with the approved guidelines, bearing the approval number “RECO2202512A” issued on May 7, 2024.

: Not applicable.

Document is current

Any future updates will be listed below